Title : A comparison of lovastatin, an HMG-CoA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia.

Pub. Date : 1995 Sep-Oct

PMID : 8595642






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Gemfibrozil significantly decreased triglyceride, very-low-density lipoprotein (VLDL), and intermediate-density lipoprotein (IDL) levels, the total cholesterol:HDL ratio, and the IDL plus VLDL;HDL ratio, and significantly increased levels of HDL, HDL2, and HDL3. Gemfibrozil HDL3 Homo sapiens
2 Gemfibrozil was significantly more effective than lovastatin in raising total HDL and HDL3 levels and in lowering the IDL plus VLDL:HDL ratio. Gemfibrozil HDL3 Homo sapiens